Edwards Lifesciences Corp

NYSE:EW

112.15

+0.58 (+0.52%)

4:00:00 PM EDT: $112.22 +0.07 (+0.06%)

Market Cap (Intraday)	70.28B
Current PE	48.06
Forward PE	49.41
2yr Forward PE	43.47

See more stats

Estimates Current Quarter

Revenue	$1.33 Billion
Adjusted EPS	$0.54

See more estimates

10-Day MA	$110.86
50-Day MA	$115.90
200-Day MA	$98.49

See more pivots

Edwards Lifesciences Corp Stock, NYSE:EW

One Edwards Way, Irvine, California 92614

United States of America

Phone: +1.949.250.2500

Number of Employees: 14900

http://www.edwards.com

Description

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart, and Critical Care. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. The Surgical Structural Heart portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The Critical Care portfolio products through hemodynamic monitoring system measures a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.